Kyle A. Beauchamp

Kyle A. Beauchamp

Stanford University

H-index: 31

North America-United States

About Kyle A. Beauchamp

Kyle A. Beauchamp, With an exceptional h-index of 31 and a recent h-index of 26 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Biophysics, ML, Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Real-world validation of the PurIST classifier demonstrates enhanced therapy selection for pancreatic ductal adenocarcinoma (PDAC) patients

Systems and methods for multi-label cancer classification

Molecular diagnostic classification for cancers of unknown primary (CUP): Post-testing diagnosis and treatment impact analysis from real-world claims data.

Nucleic acid sequencing adapters and uses thereof

182P ALK fusion detection by RNA next-generation sequencing (NGS) compared to DNA in a large, real-world non-small cell lung cancer (NSCLC) dataset

Assessing the utility of molecular diagnostic classification for cancers of unknown primary

Validation of a transcriptome-based assay for classifying cancers of unknown primary origin

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen

Kyle A. Beauchamp Information

University

Position

Biophysics Program

Citations(all)

9288

Citations(since 2020)

5636

Cited By

5895

hIndex(all)

31

hIndex(since 2020)

26

i10Index(all)

36

i10Index(since 2020)

34

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Kyle A. Beauchamp Skills & Research Interests

Biophysics

ML

Oncology

Top articles of Kyle A. Beauchamp

Title

Journal

Author(s)

Publication Date

Real-world validation of the PurIST classifier demonstrates enhanced therapy selection for pancreatic ductal adenocarcinoma (PDAC) patients

Cancer Research

Stephane Wenric

James M Davison

John Guittar

Gregory M Mayhew

Kirk Beebe

...

2024/3/22

Systems and methods for multi-label cancer classification

2023/6/15

Molecular diagnostic classification for cancers of unknown primary (CUP): Post-testing diagnosis and treatment impact analysis from real-world claims data.

Zachary Rivers

Ryan W Huey

Rotem Ben-Shachar

Anjali Narayan Avadhani

Timothy J Taxter

...

2023/6/1

Nucleic acid sequencing adapters and uses thereof

2023/12/28

182P ALK fusion detection by RNA next-generation sequencing (NGS) compared to DNA in a large, real-world non-small cell lung cancer (NSCLC) dataset

Annals of Oncology

W Iams

R Ben-Shachar

L Gai

K Beauchamp

N Sharma

...

2023/10/1

Assessing the utility of molecular diagnostic classification for cancers of unknown primary

Cancer Medicine

Elle C Moore

Gerard C Blobe

Nicholas C DeVito

Brent A Hanks

Michael R Harrison

...

2023/10

Validation of a transcriptome-based assay for classifying cancers of unknown primary origin

Molecular Diagnosis & Therapy

Jackson Michuda

Alessandra Breschi

Joshuah Kapilivsky

Kabir Manghnani

Calvin McCarter

...

2023/7

Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen

Genetics in Medicine

Kyle A Beauchamp

Katherine A Johansen Taber

Dale Muzzey

2022/4/1

Deep learning based variant calling using machine learning

2022/3/31

Abstract A003: Clinico-molecular real world data demonstrates prognostic significance of a three-gene biomarker for colorectal liver oligometastases

Cancer Research

Alia Zander

Caroline Epstein

Kabir Manghnani

Ben Terdich

Sun Hae Hong

...

2022/12/1

923P Molecular classification of cancers of unknown primary expands and refines treatment options

Annals of Oncology

DJ George

E Moore

GC Blobe

N DeVito

BA Hanks

...

2022/9/1

Real-world data to enable large-scale assessment of WHO CNS5 glioma classification.

Joshuah Kapilivsky

Kimmo J Hatanpaa

Kabir Manghnani

Timothy J Taxter

Martin Stumpe

...

2022/6/1

Variant calling using machine learning

2021/1/7

Clinical validity of expanded carrier screening: evaluating the gene‐disease relationship in more than 200 conditions

Human Mutation

Marie Balzotti

Linyan Meng

Dale Muzzey

Katherine Johansen Taber

Kyle Beauchamp

...

2020/8

Multimodal prediction of diagnosis for cancers of unknown primary

Cancer Research

Jackson Michuda

Benjamin Leibowitz

Shlomit Amar-Farkash

Crystal Bevis

Alessandra Breschi

...

2020/8/15

Cover, Volume 41, Issue 8

Human Mutation

Ceren Tunca

Tuncay Şeker

Fulya Akçimen

Cemre Coşkun

Elif Bayraktar

...

2020/8

See List of Professors in Kyle A. Beauchamp University(Stanford University)